Connect your AI

Ligand Pharmaceuticals LGND Price / sales

Price / sales at other companies

Royalty PharmaRPRX

8.4×+2.5×

LQD

Liquidia CorporationLQDA

11.5×-77.4×

RevvityRVTY

3.4×-1.2×

BridgeBio PharmaBBIO

24.8×-26.8×

Roivant SciencesROIV

2,400.1×+2,152×

Relay Therapeutics, Inc.RLAY

166.6×+109×

Other financials

Income statement

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

Market cap$5.51B+96.7%

Profitability

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Calculated from Ligand Pharmaceuticals’s reported figures.

market cap/total revenue=14.5×

Based on the most recent quarter.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ligand Pharmaceuticals's price / sales?: Ligand Pharmaceuticals (LGND) reported price / sales of 14.5× in Q1 2026.
How has Ligand Pharmaceuticals's price / sales changed year-over-year?: Ligand Pharmaceuticals's price / sales increased by 30.0% year-over-year, from 11.2× to 14.5×.
What is the long-term trend for Ligand Pharmaceuticals's price / sales?: Over 5 years (2020 to 2025), Ligand Pharmaceuticals's price / sales has grown at a 9.3% compound annual growth rate (CAGR), from 8.9× to 13.9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.